feed,title,long_url,short_url
Motley,Could This Biosimilar Drug Candidate Be a Hit for Novartis?,https://www.fool.com/investing/2022/10/03/could-this-biosimilar-drug-be-a-hit-for-novartis/?source=iedfolrf0000001,https://bit.ly/3fCdhzs
